Praxis Precision Medicines, Inc. PRAX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Praxis Precision Medicines, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s cash ratio?
- Praxis Precision Medicines, Inc. (PRAX) reported cash ratio of 10.7× in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s cash ratio changed year-over-year?
- Praxis Precision Medicines, Inc.'s cash ratio increased by 154.4% year-over-year, from 4.2× to 10.7×.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s cash ratio has grown at a -20.5% compound annual growth rate (CAGR), from 18.9× to 6×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.